CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 89 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q2 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$5,841,000
-4.3%
49,330
-4.5%
0.00%
-20.0%
Q4 2020$6,102,000
+3.2%
51,664
-2.9%
0.01%0.0%
Q3 2020$5,912,000
+10.3%
53,192
+1.4%
0.01%0.0%
Q2 2020$5,360,000
-18.3%
52,458
-13.7%
0.01%
-37.5%
Q1 2020$6,558,000
-6.1%
60,759
+1.2%
0.01%
+33.3%
Q4 2019$6,985,000
+19.0%
60,023
+17.0%
0.01%0.0%
Q3 2019$5,871,000
+97.2%
51,288
+64.2%
0.01%
+50.0%
Q2 2019$2,977,000
+8.8%
31,241
+4.2%
0.00%
+33.3%
Q1 2019$2,735,000
+17.7%
29,972
-2.1%
0.00%0.0%
Q4 2018$2,323,000
-14.4%
30,607
-9.7%
0.00%0.0%
Q3 2018$2,713,000
-23.4%
33,907
-5.0%
0.00%
-40.0%
Q2 2018$3,544,000
+8.1%
35,682
-11.8%
0.01%0.0%
Q1 2018$3,278,000
-15.0%
40,468
-17.4%
0.01%0.0%
Q4 2017$3,857,000
-6.6%
48,964
+9.4%
0.01%
-16.7%
Q3 2017$4,130,00044,7570.01%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q2 2018
NameSharesValueWeighting ↓
Kite Lake Capital Management (UK) LLP 207,382$24,135,00076.46%
Maso Capital Partners Ltd 539,597$62,798,00020.20%
York Capital Management Global Advisors, LLC 1,102,163$128,270,0007.40%
HHLR ADVISORS, LTD. 2,751,200$320,185,0003.99%
Dalton Investments, Inc. 15,551$1,810,0001.14%
Athos Capital Ltd 8,290$965,0000.96%
Myriad Asset Management Ltd. 67,019$7,799,0000.94%
Temasek Holdings (Private) Ltd 990,000$115,216,0000.75%
OXFORD ASSET MANAGEMENT LLP 211,646$24,631,0000.68%
AGF Investments America Inc. 12,230$1,423,0000.47%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders